tiprankstipranks
TipRanksTop Financial ExpertsInsidersFlagship Ventures Fund IV General Partner LLC

Flagship Ventures Fund IV General Partner LLC Insider Profile

11 Followers
Flagship Ventures Fund IV General Partner LLC, Ten Percent Owner at Rubius Therapeutics, holds 7.93M shares in Evelo Biosciences (Ticker: EVLO), holds 29.25M shares in Axcella Health (Ticker: AXLA), holds 17.25M shares in Rubius Therapeutics (Ticker: RUBY). Most recently, Flagship Ventures Fund IV General Partner LLC Bought ― shares of Evelo Biosciences on Jul 13, 2023 for an estimated value of 12.50M.
tipranks
Flagship Ventures Fund IV General Partner LLC

Flagship Ventures Fund IV General Partner LLC
Rubius Therapeutics (RUBY)
Ten Percent Owner

Ranked #95,717 out of 97,825 Corporate Insiders

Profitable Transactions

8%
1 out of 12 Profitable Transactions

Average Return

-114.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2B
99.22%
0.59%
0.16%
0.02%
<0.01% Others
A breakdown of Flagship Ventures Fund IV General Partner LLC's holdings

Insider Roles

Moderna
(MRNA)
Director, Ten Percent Owner
TransMedics Group
(TMDX)
Ten Percent Owner
Seres Therapeutics
(MCRB)
Ten Percent Owner
Evelo Biosciences
(EVLO)
Ten Percent Owner
+1 other positions
Roles that Flagship Ventures Fund IV General Partner LLC holds in companies

Most Profitable Insider Trade

Stock:
Evelo Biosciences
(EVLO)
Rating:Informative Buy
Date:Jul 01, 2020 - Jul 01, 2021
Return:+178.10%
The most profitable trade made by Flagship Ventures Fund IV General Partner LLC

Flagship Ventures Fund IV General Partner LLC's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
RUBY
Rubius Therapeutics
Mar 23, 2021
Informative Buy
6.09M
$983.45K
Kaleido Biosciences
Jun 08, 2020
Ten Percent Owner
Informative Buy
15.00M
$148.36K
TransMedics Group
Oct 31, 2019
Ten Percent Owner
Uninformative Sell
$8.94M
AXLA
Axcella Health
Oct 17, 2022
Informative Buy
17.03M
$11.70M
Moderna
Aug 19, 2020
Director, Ten Percent Owner
Uninformative Sell
$1.50B
Evelo Biosciences
Jul 13, 2023
Ten Percent Owner
Informative Buy
12.50M
$341.10K
Seres Therapeutics
Nov 25, 2020
Ten Percent Owner
Uninformative Sell
$2.43M
List of latest transactions for each holding click on a transaction to see Flagship Ventures Fund IV General Partner LLC's performance on stock

Flagship Ventures Fund IV General Partner LLC insider profile FAQ

What is the percentage of profitable transactions made by Flagship Ventures Fund IV General Partner LLC?
The percentage of profitable transactions made by Flagship Ventures Fund IV General Partner LLC is 8%.
    What is the average return per transaction made by Flagship Ventures Fund IV General Partner LLC?
    The average return per transaction made by Flagship Ventures Fund IV General Partner LLC is -114.10%.
      What stocks does Flagship Ventures Fund IV General Partner LLC hold?
      Flagship Ventures Fund IV General Partner LLC holds: RUBY, KLDO, TMDX, AXLA, MRNA, EVLO, MCRB stocks.
        What was Flagship Ventures Fund IV General Partner LLC’s latest transaction?
        Flagship Ventures Fund IV General Partner LLC latest transaction was an Informative Buy of $12.50M.
          What was Flagship Ventures Fund IV General Partner LLC's most profitable transaction?
          Flagship Ventures Fund IV General Partner LLC’s most profitable transaction was an Informative Buy of EVLO stock on July 1, 2020. The return on the trade was 178.10%.
            What is Flagship Ventures Fund IV General Partner LLC's role in Rubius Therapeutics?
            Flagship Ventures Fund IV General Partner LLC's role in Rubius Therapeutics is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.